Putting the User First: How Optel Integrates Ux Design
UX design encompasses everything that a user encounters while using a product or a service.
Major Steps in Implementing Drug Traceability
Implementing drug traceability is a long, costly and complex undertaking. So understanding these steps is important.
Everything You Need to Know About Pharmaceutical Track-and-Trace Systems
OPTEL helps pharmaceutical companies comply with traceability regulations
Why Choose OPTEL as Your L4 Provider?
OPTEL’s serialization platform is designed to help you quickly comply with serialization regulations.
Bahraïn Nhra : Tracking and Traceability Rules for the Pharmaceutical Industry
OPTEL invites you to discover the guidelines for monitoring and traceability of the pharmaceutical industry in Bahraïn
Republic of Kazakhstan: Overview of Serialization and Traceability Requirements
OPTEL lists the serialization and traceability rules for the pharmaceutical industry in republic of Kazakhstan. A complete and detailed process.
The Benefits of End-to-End Traceability in Industrial Sectors
Know the various benefits and guarantees provided by traceability in industrial sectors
Ultimate Guide of Drug Supply Chain Security Act ( DSCSA ) Timeline, Requirements and Compliance
OPTEL explains to you the Drug Supply Chain Security Act (DSCSA), critical deadlines and mandatory requirements that will be applied in 2023.
New Era of Digital Traceability
Discover with Optel a revolutionary new era of digital traceability in industries for the next decade.
RDC 658/22 (REPLACES RDC 301/19)
The online drug control described in the RDC 658/22 generates doubts. This article clarifies what each item of article 215 means.
OPTEL Is at Your Service in Your New Approaches as Pharmaceutical Exporters
Don’t know how to get started with the new pharmaceutical export measures in China? OPTEL is here to help you!
The Benefits of Digital Traceability to Minimize Food Fraud
Protect your brand by mitigating food fraud using OPTEL’s processes. Our Technologies meet your ambitions.